How should a patient with pancreatitis be evaluated?

Evaluation of Acute Pancreatitis

Diagnose acute pancreatitis with serum lipase elevation >3 times the upper limit of normal, which is more specific than amylase and should be your preferred initial test 1.

Initial Diagnostic Workup

Biochemical Confirmation

• Measure serum lipase (preferred over amylase due to higher specificity, particularly in alcoholic pancreatitis and delayed presentations) 1
• Lipase or amylase >3× upper limit of normal in the absence of renal failure confirms the diagnosis 1
• Elevations <3× upper limit have low specificity and are consistent with but not diagnostic of acute pancreatitis 1

Critical caveat: Normal amylase can occur in hyperlipidemia-induced pancreatitis, acute-on-chronic pancreatitis, or delayed presentation 2. Lipase remains elevated longer than amylase, making it superior for patients presenting days after symptom onset 2.

Mandatory Initial Laboratory Panel

At admission, obtain 1:

• Amylase or lipase
• Triglyceride level (if unavailable initially, measure fasting levels after recovery)
• Calcium level
• Complete liver panel: bilirubin, AST, ALT, alkaline phosphatase
• Complete metabolic panel to assess for organ dysfunction

Imaging Studies

Abdominal ultrasound should be performed at admission to evaluate for gallstones or bile duct obstruction 1. This is the best initial test for identifying biliary etiology.

Contrast-enhanced CT is NOT routinely needed for diagnosis but should be reserved for specific indications 1:

• Confirmation when diagnosis is uncertain
• Assessment of severity after 72 hours (early CT underestimates necrosis)
• Patients with predicted severe disease (APACHE II >8)
• Evidence of organ failure in first 72 hours

Important timing consideration: Perform CT after 72 hours to accurately assess pancreatic necrosis; earlier imaging will underestimate the extent of necrosis 1.

Severity Assessment

Use the APACHE II scoring system with a cutoff of 8 to predict severe disease and guide triage decisions 1. This is the preferred multiple factor scoring system.

Define Severe Disease By:

• Mortality
• Organ failure (multiorgan failure and persistent/progressive organ failure are most predictive of mortality) 1
• Local complications: pseudocyst, necrosis, or abscess 1

Additional Severity Markers

• C-reactive protein >150 mg/L at 48 hours is the preferred laboratory adjunct for severity prediction 1
• Patients with APACHE II >8, actual severe disease, persistent organ failure, or severe comorbidities should be triaged to ICU or intermediate care 1

Etiologic Evaluation

The etiology should be established in at least 75% of patients 1. Focus your history on:

• Previous gallstone symptoms or documentation
• Alcohol use patterns
• Hypertriglyceridemia or hypercalcemia history
• Family history of pancreatic disease
• All medications (prescription and over-the-counter)
• Trauma history
• Autoimmune disease presence

Age-Specific Malignancy Screening

Perform CT or endoscopic ultrasound (EUS) in patients >40 years old with unexplained pancreatitis to evaluate for underlying pancreatic malignancy 1.

Recurrent Pancreatitis Evaluation

• Single episode in patients <40 years: Extensive evaluation NOT recommended 1
• Recurrent episodes: Evaluate with EUS and/or ERCP, with EUS preferred as the initial test 1
• If ERCP is performed, ensure it's done by an experienced endoscopist capable of therapeutic interventions (sphincterotomy, stent placement, manometry) 1

Biliary Pancreatitis Considerations

If initial ultrasound is inadequate or suspicion remains high:

• Repeat ultrasound after recovery
• EUS is an accurate alternative for screening cholelithiasis and choledocholithiasis 1

Key Pitfalls to Avoid

1. Don't order daily enzyme measurements after diagnosis—they provide no value in assessing clinical progress or prognosis 2
2. Don't perform early CT (<72 hours) for severity assessment—it will underestimate necrosis 1
3. Don't miss hyperlipidemia-induced pancreatitis—amylase may be falsely normal; check triglycerides 1, 2
4. Don't overlook biliary etiology—ultrasound at admission is mandatory, not optional 1
5. Don't dismiss acute pancreatitis in patients with unexplained multiorgan failure or SIRS—consider it in the differential 1